Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.

Meader N.

Drug Alcohol Depend. 2010 Apr 1;108(1-2):110-4. doi: 10.1016/j.drugalcdep.2009.12.008. Epub 2010 Jan 13. Review.

PMID:
20074867
2.

Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.

Gish EC, Miller JL, Honey BL, Johnson PN.

Ann Pharmacother. 2010 Feb;44(2):343-51. doi: 10.1345/aph.1M347. Epub 2009 Dec 29. Review.

PMID:
20040696
3.

Alpha2-adrenergic agonists in opioid withdrawal.

Gowing LR, Farrell M, Ali RL, White JM.

Addiction. 2002 Jan;97(1):49-58. Review.

PMID:
11895270
4.

Buprenorphine for managing opioid withdrawal.

Gowing L, Ali R, White JM, Mbewe D.

Cochrane Database Syst Rev. 2017 Feb 21;2:CD002025. doi: 10.1002/14651858.CD002025.pub5. Review.

PMID:
28220474
5.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
6.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002025. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002025.

PMID:
15495026
7.

A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.

Raistrick D, West D, Finnegan O, Thistlethwaite G, Brearley R, Banbery J.

Addiction. 2005 Dec;100(12):1860-7.

PMID:
16367987
8.

Alpha2 adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White J.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD002024. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD002024.

PMID:
15495025
9.

Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.

Amato L, Davoli M, Ferri M, Gowing L, Perucci CA.

Drug Alcohol Depend. 2004 Mar 8;73(3):219-26.

PMID:
15036544
10.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
11.

In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.

McCambridge J, Gossop M, Beswick T, Best D, Bearn J, Rees S, Strang J.

Drug Alcohol Depend. 2007 Apr 17;88(1):91-5. Epub 2006 Oct 24.

PMID:
17064857
12.

Alpha2 adrenergic agonists for the management of opioid withdrawal.

Gowing L, Farrell M, Ali R, White J.

Cochrane Database Syst Rev. 2003;(2):CD002024. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD002024.

PMID:
12804419
13.

[Buprenorphine or methadone for detoxification of young opioid addicts?].

Ebner R, Schreiber W, Zierer C.

Psychiatr Prax. 2004 Nov;31 Suppl 1:S108-10. German.

PMID:
15570521
14.

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.

Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, Wiese B, Emrich HM, Schneider U.

Pharmacopsychiatry. 2002 Sep;35(5):159-64.

PMID:
12237786
15.

The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A.

Br J Gen Pract. 2005 Feb;55(511):139-46. Review.

16.

Buprenorphine for the management of opioid withdrawal.

Gowing L, Ali R, White J.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002025. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD002025.

PMID:
16625553
17.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Mattick RP, Kimber J, Breen C, Davoli M.

Cochrane Database Syst Rev. 2004;(3):CD002207. Review. Update in: Cochrane Database Syst Rev. 2008;(2):CD002207.

PMID:
15266465
18.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Mattick RP, Kimber J, Breen C, Davoli M.

Cochrane Database Syst Rev. 2003;(2):CD002207. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD002207.

PMID:
12804429
19.

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Mattick RP, Kimber J, Breen C, Davoli M.

Cochrane Database Syst Rev. 2002;(4):CD002207. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD002207.

PMID:
12519569
20.

Supplemental Content

Support Center